Experiment 943638
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | EDER,JP: WHEELER,CA: TEICHER,BA: SCHNIPPER,LE:. (1991). A PHASE I CLINICAL TRIAL OF NOVOBIOCIN, A MODULATOR OF ALKYLATING AGENT CYTOTOXICITY.. 51(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | 39 PATIENTS WERE USED IN THIS PHASE 1 TRIAL. DOSE LIMITING TOXICITY WAS VOMITING. PATIENTS ALSO EXPERIENCED MYLOSUPPRESSION AND ALLERGIC REACTIONS. 2 PATIENTS HAD A PARTIAL RESPONSE TO TREATMENT, 4 HAD STABLE DISEASE. |
| Dose amount | 750.0 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |